Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model

By Gomis-González Maria   Busquets-Garcia Arnau   Matute Carlos   Maldonado Rafael   Mato Susana   Ozaita Andrés  

Genes, Vol. 7, Iss. 9, 2016-08 ,pp. : 56-56

MDPI

Access to resources Recommend Favorite

Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance

By Mesalam Ahmed Atef   Vercauteren Koen   Meuleman Philip  

Viruses, Vol. 8, Iss. 6, 2016-06 ,pp. : 176-176

MDPI

Access to resources Recommend Favorite

Inhibition of Acetylcholinesterase Modulates NMDA Receptor Antagonist Mediated Alterations in the Developing Brain

By Bendix Ivo   Serdar Meray   Herz Josephine   von Haefen Clarissa   Nasser Fatme   Rohrer Benjamin   Endesfelder Stefanie   Felderhoff-Mueser Ursula   Spies Claudia D.   Sifringer Marco  

International Journal of Molecular Sciences, Vol. 15, Iss. 3, 2014-03 ,pp. : 3784-3798

MDPI

Access to resources Recommend Favorite

Functional and Structural Brain Changes Associated with Methamphetamine Abuse

By Jan Reem K.   Kydd Rob R.   Russell Bruce R.  

Brain Sciences, Vol. 2, Iss. 4, 2012-10 ,pp. : 434-482

MDPI

Access to resources Recommend Favorite

Neurodegeneration and Sensorimotor Deficits in the Mouse Model of Traumatic Brain Injury

By Bhowmick Saurav   D‘Mello Veera   Ponery Nizmi   Abdul-Muneer P. M.  

Brain Sciences, Vol. 8, Iss. 1, 2018-01 ,pp. : 11-11

MDPI

Access to resources Recommend Favorite